Nuo Therapeutics AURX
OTC AURX
$1.29 +0.03 (+2.46%)
As of: Oct 21, 2026 · 12:22 PM EDT

Nuo Therapeutics (AURX) Convertible Debt (2012 - 2019)

Updated

Nuo Therapeutics (AURX) reported Convertible Debt of $350,000 for Q1 2019, unchanged from the prior quarter.

Analysis

Nuo Therapeutics (AURX) Convertible Debt (2012 - 2019) Analysis & Trends

Dating back to Q4 2012, Nuo Therapeutics' Convertible Debt record includes 12 quarters.

  • Convertible Debt has a five-year compound annual growth rate of 11.5% (FY2013 to FY2018).
  • By year, Convertible Debt came in at $38.1 million in FY2015 and $325,553 in FY2014 (+60.6%).
  • Five-year quarterly Convertible Debt spans a low of $194,444 in Q2 2014 and a high of $38.1 million in Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 254.21 Bn 233.23 Bn 4.88 Bn
2 Abbott Laboratories 176.12 Bn 146.55 Bn 7.27 Bn
3 Danaher 164.23 Bn 148.04 Bn 3.61 Bn
4 Intuitive Surgical 155.68 Bn 135.10 Bn 1.96 Bn
5 Medtronic 121.85 Bn 87.10 Bn 6.34 Bn
6 Stryker 117.33 Bn 103.45 Bn 4.50 Bn
7 Boston Scientific 66.63 Bn 61.40 Bn 3.85 Bn
8 Becton Dickinson 54.34 Bn 51.49 Bn 2.32 Bn
9 Edwards Lifesciences 51.61 Bn 35.62 Bn 1.35 Bn
10 Nuo Therapeutics 61.03 Mn 59.20 Mn 1.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 350,000.00
Dec 31, 2018 350,000.00
Sep 30, 2018 350,000.00
Dec 31, 2015 38.10 Mn
Jun 30, 2015 37.10 Mn
Mar 31, 2015 36.50 Mn
Dec 31, 2014 325,553.00
Sep 30, 2014 251,600.00
Jun 30, 2014 194,444.00
Mar 31, 2014 75,252.00
Dec 31, 2013 202,658.00
Dec 31, 2012 462,815.00
API Access

Nuo Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=AURX&period=max&api_key=YOUR_API_KEY